Japan plans to revise its guidelines on the drone delivery of medicines later this month, which would mark the first revision since they were established two years ago. Service providers are closely watching how they will be revised, with calls…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Top-3 GE Makers Report 10.4% Increase in Sales; Pace Down from Year Before
November 11, 2011
-
REGULATORY MHLW Proposes Raising GE Dispensing Rates to Receive Upper Premiums for GE Dispensing Systems
November 10, 2011
-
REGULATORY Applications for “Regulatory Strategy Consultation” Increasing Rapidly: Mr Isobe of PMDA
November 10, 2011
-
BUSINESS Operating Profit Rate for Top-4 Wholesalers Slips to 0.39% in April-September
November 9, 2011
-
BUSINESS Astellas, RIKEN to Explore, Jointly Develop Novel Drug Targets for AD
November 9, 2011
-
BUSINESS Towa Pharmaceutical Developing Lipitor Generic Version OD Tablets
November 9, 2011
-
BUSINESS Towa Pharmaceutical’s New Business Plan is “Groundwork for Future Progress”
November 8, 2011
-
BUSINESS Suzuken President Ota Says Wholesale Business Recovery Crucial
November 8, 2011
-
BUSINESS 8 of 10 Leading Drug Makers Report Declines in 1st-Half Sales
November 7, 2011
-
REGULATORY CSIMC Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 4, 2011
-
BUSINESS Eisai President Says Japan, China to Become Key Battlefields for Aricept
November 2, 2011
-
BUSINESS Marketing of Imusera, Telavic to Be Limited to Specialists at First: MTPC
November 2, 2011
-
BUSINESS DSP to Boost Domestic CNS Business for Early Maximization of Lonasen
November 1, 2011
-
BUSINESS Shionogi’s Strength in Japan Weakened by Slack US Results, Overall Sales Down 13.5% in Apr-Sept
November 1, 2011
-
BUSINESS DSP: Strong Yen Contributes to 5.6% Decline in Sales
November 1, 2011
-
REGULATORY Drug-induced Hepatitis Victims, Lawyers Petition Against Establishment of “Third Party Organization”
October 31, 2011
-
ACADEMIA JSGM Calls for Elimination of GE Drug Refusal Option in Prescriptions
October 28, 2011
-
REGULATORY Subcommittee to Recommend Use of Most-recent 3-Year Averages in Drug Cost Calculation
October 27, 2011
-
REGULATORY DPJ Lawmakers Opposed to TPP Criticize MHLW at Hearings
October 27, 2011
-
BUSINESS GSK CEO Thinks Highly of Premiums for New Drug Creation, Key to Attractive Market
October 26, 2011
ページ
The healthcare supply chain in Japan, as in all major markets, consists of biopharmaceutical manufacturers selling to wholesalers who in turn sell to hospitals, clinics, and pharmacies, where the drugs are finally dispensed to patients. Each party ideally contributes value…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…